Rossari Biotech Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA132195229
EBIT109147167
Earning Per Share151719
Expenses5861,3001,433
Net Profit8096106
Net Profit Margin1166
Operating Profit Margin191314
Profit Before Tax106135143
Dividends Per Share111
Operation Revenue7191,4951,661

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023002,436NA2,742
2022241.71290.05176.101,273.85240.60
2022182.64212.26127.90585.59176.10
2022235.68299.64167.901,491.45222.20
2023196.79205.88135.93NA194.79
The EBITDA of Rossari Biotech is 229 as of 11/28/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019201920192020
Operating Activities2471717157
Investing Activities-20-36-36-36-190
Financing Activities-5-29-29-29157
Others00000
Net Cash Flow-266623

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20232,971-1,186-2,076-291
2023281.98-216.78-53.7711.43
2023237.93-142.74-112.48-17.30
2023285.83-204.44-91.42-10.03
2023140.11-15.32-49.7775.02
The cash flow from Operating Activities of Rossari Biotech is 57 as of 11/28/2023